Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-25T06:30:19.528Z Has data issue: false hasContentIssue false
  • English
  • Français

Monoamine Oxidase in Chronic Schizophrenia

Studies of Hormonal and other Factors affecting Enzyme Activity

Published online by Cambridge University Press:  29 January 2018

Dennis L. Murphy ,
Robert Belmaker ,
William T. Carpenter  and
Richard J. Wyatt
Dennis L. Murphy
Affiliation:
Section on Clinical Neuropharmacology, Laboratory of Clinical Science, National Institute of Mental Health, NIH Clinical Center, Bldg 10/3S229, Bethesda, Maryland 20014
Robert Belmaker
Affiliation:
The Department of Research, Jerusalem Mental Health Centre, Ezrat Nashim, Jerusalem, Israel
William T. Carpenter
Affiliation:
Department of Psychiatry, Albert Einstein College of Medicine, New York
Richard J. Wyatt
Affiliation:
Division of Special Mental Health Research, National Institute of Mental Health, St Elizabeth's Hospital, Washington, DC
Get access Rights & Permissions [Opens in a new window]

Summary

Reported reductions in the activity of platelet monoamine oxidase (MAO) in chronic schizophrenic patients might be contributed to by alterations in hormones, platelet numbers or other non-specific factors thought to affect enzyme activity. In this study, MAO activity in 27 patients with chronic schizophrenia was measured, using benzylamine as the substrate in an assay based on platelet counts instead of platelet protein, and was found to be markedly lower than mean MAO activity in 375 normal controls. These results were similar to those previously reported with tryptamine as a substrate for the enzyme. Serum testosterone, triiodothyronine, iron and iron-binding capacity were within normal ranges in individuals with reduced MAO activity, and none of these measurements was significantly correlated with MAO activities. Platelet MAO activity remained stable over time in patients and controls.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 130 , Issue 2 , February 1977 , pp. 151 - 158
Copyright
Copyright © Royal College of Psychiatrists 1977 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Belmaker, R., Murphy, D. L., Wyatt, R.J. & Loriaux, L. (1974) Human platelet monoamine oxidase changes during the menstrual cycle. Archives of General Psychiatry, 31, 553–6.Google Scholar
Brambilla, F. & Penati, G. (1970) Hormones and behavior in Schizophrenia. In Influence of Hormones on the Nervous System, Proc. Int. Soc. Psychoneuroendocrinology, pp 482–94, Brooklyn.CrossRefGoogle Scholar
Carpenter, W. T., Murphy, D. L. & Wyatt, R. J. (1975) Platelet monoamine oxidase activity in acute schizophrenia. American Journal of Psychiatry, 132, 438–41.Google ScholarPubMed
Chopra, I. J., Ho, R. S. & Lam, R. (1972) An improved radioimmunoassay of triidothyronine in serum: its application to clinical and physiological studies. Journal of Laboratory and Clinical Medicine, 80, 729–39.Google Scholar
Cookson, I. B., Owen, F. & Ridges, A. P. (1975) Platelet monoamine oxidase activity during the course of a schizophreniform psychosis. Psychological Medicine, 314–16.Google Scholar
Domino, E. F. & Khanna, S. S. (1976) Decreased blood platelet MAO activity in unmediated chronic schizophrenic patients. American Journal of Psychiatry, 133, 323–6.Google Scholar
DSM-II (1968) Diagnostic and Statistical Manual of Mental Disorders, Second Edition. Washington: American Psychiatric Association.Google Scholar
Friedman, E. Shopsin, B., Sathananthan, G. & Gershon, S. (1974) Blood platelet MAO activity in psychiatric patients. American Journal of Psychiatry, 131, 1392–4.Google Scholar
Gaziri, L. C. J. & Ladosky, W. (1973) Monoamine oxidase variation during sexual differentiation. Neuroendocrinology, 12, 249–56.Google Scholar
Gentil, V., Greenwood, M. H. & Lader, M. H. (1975) The effect of adrenaline on human platelet MAO. Psychopharmocologia, 44, 187–94.Google Scholar
Goridis, C. & Neff, N. H. (1973) Neuronal and hormonal influences on the turnover of monoamine oxidase in salivary gland. Biochemical Pharmacology, 22, 2501–10.CrossRefGoogle ScholarPubMed
Ho-Van-Hap, A., Babineau, L. M. & Berlinguet, L. (1967) Hormonal action on monoamine oxidase activity in rats. Canadian Journal of Biochemistry, 45, 355–62.Google Scholar
Levine, R. J., Oates, J. A., Vendsalu, A. & Sjoerdsma, A. (1962) Studies of the metabolism of aromatic amines in relation to altered thyroid function in man. Journal of Clinical Endocrinology and Metabolism, 22, 1242–50.Google Scholar
Lyles, G. A. & Callingham, B. A. (1974) The effects of thyroid hormones on monoamine oxidase in the rat heart. Journal of Pharmacy and Pharmacology, 26, 921–30.Google Scholar
Meltzer, H. Y. & Stahl, S. M. (1974) Platelet monoamine oxidase activity and substrate preferences in schizophrenia patients. Research Communications in Chemical Pathology and Pharmacology, 7, 419–31.Google Scholar
Miller, G. L. (1959) Protein determinations for large numbers of samples. Analytic Chemistry, 31, 964.Google Scholar
Murphy, D. L., Belmaker, R. & Wyatt, R. J. (1974) Monoamine oxidase in schizophrenia and other behavioral disorders. Journal of Psychiatric Research, 11, 221–48.Google Scholar
Murphy, D. L. & Wyatt, R. J. (1972) Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature, 238, 225–6.CrossRefGoogle ScholarPubMed
Murphy, D. L. & Wyatt, R. J. (1975) Enzyme studies in the major psychiatric disorders: I. Catechol-O-methyl-transferase, monoamine oxidase in the affective disorders, and factors affecting some behavior-related enzyme activities. In The Biology of the Major Psychoses: A Comparative Analysis (ed Freedman, D. S.), pp 277–88. New York: Raven Press.Google Scholar
Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L. & Wyatt, R. J. (in press) Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem. med. Google Scholar
Nies, A., Robinson, D. S., Harris, L. S. & Lamborn, K. R. (1974) Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls. In Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes (ed. Usdin, E.), pp 59–70. New York: Raven Press.Google Scholar
Redmond, D. E., Baulu, J., Murphy, D. L., Loriaux, D. L., Ziegler, M. G. & Lake, C. R. (in press) Effects of testosterone on plasma and platelet monoamine oxidase and plasma dopamine β-hydroxylase activities in the male rhesus monkey. Psychosomatic Medicine. Google Scholar
Redmond, D. E., Murphy, D. L., Ziegler, M. G., Lake, C. R. & Baulu, J. (1975) Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma dopamine beta-hydroxy-lase (DBH) activities in the rhesus monkey. Psychosomatic Medicine, 37, 417–28.CrossRefGoogle ScholarPubMed
Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. L. & Sylwester, D. (1971) Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Archives of General Psychiatry, 24, 536–9.Google Scholar
Shaskan, E. G. & Becker, R. E. (1975) Platelet monoamine oxidase in schizophrenics. Nature, 253, 659–60.CrossRefGoogle ScholarPubMed
Thorneycroft, I. H. & Stone, S. C. (1972) Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroids. Contraception, 5, 129–46.Google Scholar
Wurtman, R. J. & Axelrod, J. (1963) Sex steroids, cardiac 3H-norepinephrine, and tissue monoamine oxidase levels in the rat. Biochemical Pharmacology, 12, 1417–19.Google Scholar
Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, C. H. & Pollin, W. (1973) Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia. Science, 179, 916–18.CrossRefGoogle ScholarPubMed
Yee, H. Y. & Zin, A. (1971) An autoanalyzer procedure for serum iron and total iron-binding capacity, with use of ferrozine. Clinical Chemistry, 17, 950–3.CrossRefGoogle ScholarPubMed
Youdim, M. B. H., Woods, H. F., Mitchell, B., Grahame-Smith, D. G. & Callender, S. (1975) Human platelet monoamine oxidase activity in iron-deficiency anaemia. Clinical Science and Molecular Medicine, 48, 280–95.Google Scholar
Zeller, E. A., Boshes, B., Davis, J. M. & Thorner, M. (1975) Molecular aberration in platelet monoamine oxidase in schizophrenia. Lancet, i, 1385.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.